Treatment emergent adverse events at least possibly related to the study treatment (N = 24)
| Adverse events . | All grade . | Grade 3-4 . |
|---|---|---|
| No. of patients with events, N (%) . | ||
| Skin rash | 6 (25) | 0 |
| Easy bruising | 5 (21) | 0 |
| Arthralgia | 5 (21) | 0 |
| Lung infection/pneumonia | 3 (12) | 1 (4) |
| Diarrhea | 2 (8) | 0 |
| Myalgia | 2 (8) | 0 |
| Amylase/lipase elevation | 1 (4) | 1 (4) |
| Transaminitis | 1 (4) | 1 (4) |
| Uveitis | 1 (4) | 1 (4) |
| Pneumonitis | 1 (4) | 0 |
| Atrial fibrillation | 1 (4) | 0 |
| Infusion reaction | 1 (4) | 0 |
| Vomiting | 1 (4) | 0 |
| Adverse events . | All grade . | Grade 3-4 . |
|---|---|---|
| No. of patients with events, N (%) . | ||
| Skin rash | 6 (25) | 0 |
| Easy bruising | 5 (21) | 0 |
| Arthralgia | 5 (21) | 0 |
| Lung infection/pneumonia | 3 (12) | 1 (4) |
| Diarrhea | 2 (8) | 0 |
| Myalgia | 2 (8) | 0 |
| Amylase/lipase elevation | 1 (4) | 1 (4) |
| Transaminitis | 1 (4) | 1 (4) |
| Uveitis | 1 (4) | 1 (4) |
| Pneumonitis | 1 (4) | 0 |
| Atrial fibrillation | 1 (4) | 0 |
| Infusion reaction | 1 (4) | 0 |
| Vomiting | 1 (4) | 0 |